MAPT and ischemia: Moreover, reducing Tau hyperphosphorylation with GSK-3β inhibitors such as nimodipine or by the administration of glucosamine, which by promoting O-GlcNAcylation antagonizes phosphorylation, has shown neuroprotective effects in rodent models of ischemia [20, 87].